’s latest new coronavirus specific drug is the ambavirumab and romisevirumab combination therapy that has been making a lot of noise recently. The manufacturer claims that the drug is quick-acting and effective, but the price is around five digits, or ten thousand yuan, which is currently not within the reach of ordinary people like us.
In the eyes of most people, this price is indeed outrageous. But considering that it is mainly targeted at special groups of people with a large number of viruses in their bodies, the drug is actually not very urgent for us ordinary people. Because ordinary people are mainly asymptomatic and will naturally recover after receiving isolation treatment for a period of time. Those who really need it may be the elderly, but at this price, the elderly generally will not choose to use it. It can be said that the price dissuades buyers.
But on the other hand, it is also good news. After all, special medicines have been released. Although the price is high now and there are few buyers, as time goes by, the price of special medicines will also decrease, and special medicines for civilians will gradually become available. will become popular. After all, when the epidemic first emerged, a nucleic acid test for and cost hundreds of yuan, but now it only costs 3.5 yuan for a mixed test.
With this beginning, everyone should be more confident. I believe that there will be more and more effective COVID-19 drugs at affordable prices in the future, so that the epidemic crisis can be truly overcome.
